Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Alzheimer's disease proteome-wide association study implicates adaptive immunity and identifies risk genes LILRB1 and SIRPA.

Science translational medicine·2026
Same author

Accelerometer-derived daily steps, cognition, and cognitive impairment in U.S. community-dwelling older adults: The Atherosclerosis Risk in Communities Study.

Alzheimer's & dementia (New York, N. Y.)·2026
Same author

Frailty as a Modifier of the Associations Between Vascular Risk Factors and Incident Dementia.

Neurology·2026
Same author

Orthostatic Blood Pressure, Cardiovascular Disease, and Hypotensive Events.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

Examining the Relevance of Gait Speed Resiliencies to Different Stressors: the ARIC Study.

The journals of gerontology. Series A, Biological sciences and medical sciences·2026
Same author

Associations of blood biomarkers of glial cell dysfunction and neuronal injury with future cognitive decline and incident dementia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Patient-derived forebrain cortical organoids reveal biphasic tau-MAP6-microtubule axis dysfunction in tauopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Genetic architecture of the limbic white matter microstructure in aging and Alzheimer's Disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Greater choroid plexus volume is linked to poor sleep, neurodegeneration, and cognitive deficits in older adults: Evidence from the IGNITE Study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Plasma-based neurobiological protein biomarkers as predictors of dementia progression: Insights from longitudinal aging study in India - Diagnostic assessment of dementia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Neuropathology-specific language features in primary progressive aphasia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Dementia blood biomarkers in the context of post-stroke cognitive outcomes: Systematic review and evidence synthesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Srishti Shrestha1, Xiaoqian Zhu1, B Gwen Windham1

  • 1University of Mississippi Medical Center, The MIND Center, Jackson, MS, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
PubMed
概括
此摘要是机器生成的。

针对质和神经元功能障碍以及神经炎症的血液生物标志物与成年人更快的认知衰退和痴呆风险增加有关. 这些标记可能有助于识别患阿尔茨海默病和相关痴呆症 (ADRD) 风险较高的个体.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经学 神经学
  • 生物标志物研究 生物标志物研究
  • 老年学是一门学科.

背景情况:

  • 对阿尔茨海默病和相关痴呆症 (ADRDs) 生物标志物的研究主要集中在粉样β和病理上.
  • 在社区群体中研究质和神经元功能障碍和神经炎症的生物标志物的研究是有限的.
  • 这项研究检查了与认知衰退和痴呆风险相关的新型血液生物标志物.

研究的目的:

  • 为了研究血液生物标志物反映质/神经元功能障碍和神经炎症与25年内认知能力下降的关联.
  • 评估这些生物标志物与发展痴呆症的风险之间的关系.
  • 探索这些生物标志物在早期ADRD诊断和风险分层中的实用性.

主要方法:

  • 来自ARIC研究的1864名参与者接受了血液生物标志物 (sCD14,YKL-40,GFAP,NfL,总-Tau,UCH-L1) 的测量.
  • 认知功能在25年内被评估了多达6次,并且通过各种确定方法确定了痴呆病例.
  • 使用共享参数模型分析与每个生物标志物相关的认知衰退和痴呆风险,并对共变量进行调整.

主要成果:

  • 大多数生物标志物的较高水平 (除UCH-L1外的所有生物标志物) 与更快的认知衰退和痴呆风险增加有关.
  • 例如,YKL-40的一个SD增加与更的认知衰退和59%更高的痴呆风险有关.
  • sCD14还与加速的认知衰退和38%的痴呆风险增加有关.

结论:

  • 血中的生物标志物表明微质激活,星细胞反应和神经元退化与认知能力下降和痴呆风险有关.
  • 这些发现表明,这些生物标志物在ADRD风险分层和干预策略中具有潜在的实用性.
  • 进一步的研究将探讨基于种族和APOE-ε4地位的这些协会的差异.